Toth Financial Advisory’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2K Sell
2,000
-65
-3% -$859 ﹤0.01% 453
2026
Q1
$28.5K Hold
2,065
﹤0.01% 434
2025
Q4
$37.2K Hold
2,065
﹤0.01% 395
2025
Q3
$38.3K Buy
+2,065
New +$32.4K ﹤0.01% 390
2024
Q2
Sell
-100
Closed -$1.11K 758
2024
Q1
$1.11K Sell
100
-100
-50% -$1.02K ﹤0.01% 676
2023
Q4
$1.73K Hold
200
﹤0.01% 631
2023
Q3
$1.53K Hold
200
﹤0.01% 664
2023
Q2
$1.44K Hold
200
﹤0.01% 693
2023
Q1
$1.22K Hold
200
﹤0.01% 733
2022
Q4
$872 Hold
200
﹤0.01% 675
2022
Q3
$1K Hold
200
﹤0.01% 676
2022
Q2
$1K Buy
+200
New +$1.04K ﹤0.01% 636

Other funds holding CLBT

Toth Financial Advisory's CLBT Position: Q2 2026 in Review

Toth Financial Advisory reduced its Cellebrite (CLBT) stake by 3.1% in Q2 2026, selling an estimated $859 and leaving 2,000 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Toth Financial Advisory first reported a position in CLBT in Q2 2022 and has held it in 12 quarters since. The position peaked at $38.3K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Toth Financial Advisory held 2,000 shares of Cellebrite worth $29.2K as of Q2 2026.
  • Toth Financial Advisory sold 65 Cellebrite shares in Q2 2026, an estimated $859.
  • Cellebrite made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #453 holding.
  • Toth Financial Advisory first reported a position in Cellebrite in Q2 2022 and has held it in 12 quarters since.
  • Toth Financial Advisory's Cellebrite position peaked at $38.3K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.